三维超声诊断子宫腺肌症与单囊胚移植妊娠结局无关
该前瞻性队列研究纳入648例接受单囊胚移植的不孕患者,三维超声诊断子宫腺肌症患病率为15.3%,评估者间一致性差(κ=0.23)。调整混杂因素后,子宫腺肌症与临床妊娠、流产及活产率均无显著差异,提示无症状患者常规筛查可能不必要。
要点
- 三维超声诊断子宫腺肌症的评估者间一致性差(κ=0.23)。
- 子宫腺肌症组与无子宫腺肌症组的活产率相似(69.5% vs 66.5%)。
- 无症状不孕患者冻胚移植前常规筛查子宫腺肌症可能不必要。
核心结论
- 三维超声评估子宫腺肌症的评估者间一致性差。
- 无症状患者的三维超声子宫腺肌症标志物可能与单囊胚移植后妊娠结局无关。
研究设计与样本
- 前瞻性队列研究,纳入2017年4月至12月期间计划接受单囊胚移植的648例受试者。
- 胚胎移植前一天进行三维超声检查,图像由五名生殖内分泌专家独立评估七项子宫腺肌症超声特征。
主要发现
- 子宫腺肌症的超声患病率为15.3%(99/648)。
- 评估者间一致性差(κ=0.23),评估者内一致性中等(κ=0.58)。
- 子宫腺肌症组年龄较大(37.1 vs 35.9岁,P=0.02),更可能采用GnRH激动剂降调节方案(12.1% vs 5.1%,P=0.02)。
- 临床妊娠率(80.0% vs 75.0%)和活产率(69.5% vs 66.5%)两组相似。
- 调整混杂因素后,临床妊娠(aOR 1.47,95%CI 0.85-2.56)、流产(aOR 1.3,95%CI 0.62-2.72)和活产(aOR 1.28,95%CI 0.78-2.08)均无显著差异。
关键数值与推荐
- 子宫腺肌症的超声诊断标准为多数评估者注意到七项超声特征中的至少一项。
- 七项超声特征包括:全局性子宫增大、肌层壁不对称、不均匀回声、交界区不规则、肌层囊肿、扇形阴影和边界不清的肌层病变。
临床怎么用
- 对于无症状的不孕患者,冻胚移植前常规三维超声筛查子宫腺肌症可能不必要。
- 三维超声诊断子宫腺肌症需注意评估者间一致性较差的问题。
局限性
- 研究纳入的是无症状或症状很少的患者人群,结论可能不适用于有症状的子宫腺肌症患者。
- 评估者间一致性差可能影响诊断准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objectives of this study were (1) to assess the prevalence of ultrasound (US) features of adenomyosis in an infertile population undergoing in-vitro fertilization (IVF), (2) to define the inter- and intrarater agreement of three-dimensional (3D) US assessment of adenomyosis, and (3) to evaluate sonographic features of adenomyosis with respect to pregnancy outcome following transfer of a single thawed euploid blastocyst. METHODS: This was a prospective cohort study. Subjects scheduled to undergo a single thawed euploid blastocyst transfer between April and December 2017 at a large IVF center were eligible for inclusion. Enrolled subjects underwent endometrial preparation for frozen embryo transfer. 3D-US was performed on the day prior to embryo transfer, with images stored for subsequent evaluation. Subjects then underwent transfer of a single thawed euploid blastocyst, and pregnancy outcomes were collected. All 3D-US volumes were de-identified and reviewed independently by five reproductive endocrinologists/infertility specialists with expertise in gynecological US for the presence of seven sonographic features of adenomyosis: global uterine enlargement, myometrial wall asymmetry, heterogeneous echogenicity, irregular junctional zone, myometrial cysts, fan-shaped shadowing and ill-defined myometrial lesions. Adenomyosis was considered to be present if the majority of the reviewers noted at least one of the seven sonographic features. Inter- and intrarater agreement was evaluated using Fleiss's kappa. Clinical and cycle characteristics of subjects with and those without adenomyosis were compared. The primary outcome of interest was live birth rate. Secondary outcomes included clinical pregnancy rate and miscarriage rate. Logistic regression analysis was performed to account for potential confounders. RESULTS: A total of 648 subjects were included. The prevalence of adenomyosis on US was 15.3% (99/648). On retrospective chart review, very few patients with adenomyosis had symptoms. The inter- and intrarater agreement amongst five independent specialists conducting the 3D-US assessments of adenomyosis were poor (κ = 0.23) and moderate (κ = 0.58), respectively. Subjects with adenomyosis were older (37.1 vs 35.9 years, P = 0.02) and more likely to undergo a gonadotropin-releasing hormone agonist downregulation protocol when compared with those without adenomyosis (12.1% vs 5.1%, P = 0.02). Clinical pregnancy (80.0% vs 75.0%) and live birth (69.5% vs 66.5%) rates were similar between the groups. When adjusting for potential confounders, there was no difference in the rate of clinical pregnancy (adjusted odds ratio (aOR), 1.47 (95% CI, 0.85-2.56)), miscarriage (aOR, 1.3 (95% CI, 0.62-2.72)) or live birth (aOR, 1.28 (95% CI, 0.78-2.08)) between subjects with and those without adenomyosis. No individual sonographic marker of adenomyosis was predictive of pregnancy outcome. CONCLUSIONS: The inter-rater agreement of 3D-US assessment of adenomyosis is poor. Furthermore, sonographic markers of adenomyosis in asymptomatic patients may not be associated with altered pregnancy outcome following transfer of a single thawed euploid blastocyst. These findings suggest that routine screening for asymptomatic adenomyosis in an unselected infertile patient population undergoing frozen embryo transfer may not be warranted. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Neal S, Morin S, Werner M, et al. Three-dimensional ultrasound diagnosis of adenomyosis is not associated with adverse pregnancy outcome following single thawed euploid blastocyst transfer: prospective cohort study. Ultrasound Obstet Gynecol. 2020. PMID: 32349167. doi:10.1002/uog.22065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。